Evado signs distribution deal
Monday, 14 April, 2008
Specialist life science training, quality assurance and regulatory compliance company SeerPharma has signed a re-seller agreement with Evado, a division of Australian company Invision IT Systems.
SeerPharma will distribute Evado's new web-based enterprise pre-clinical, clinical and mobile software modules in the SE Asian region. SeerPharma will also offer Evado as a software-as-a-service (SaaS) application to its medical device, biotechnology and life science clients.
Evado is a form-based technology that replaces the paper-based case report forms with easy to customise templates that are suitable for drug or device trials.
"Evado was created to provide a simple, easy-to-use, economical alternative to expensive clinical trial software," Evado's CEO Jennie Anderson said.
"Evado helps speed up clinical trials and assists researchers in the development of new medical therapies and medical devices by reducing costs and by improving data accuracy thereby achieving quicker regulatory approvals and time to market."
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...
Maternal cannabis use puts kids at risk of behavioural problems
Children exposed to their mother's cannabis use during pregnancy and after birth are three...
